HIGHLIGHTS
- who: Meron M. Kifle from the Medicine, London, UKSetting: Oxford University Hospitals, Oxford, United Kingdom (UK) have published the Article: The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial, in the Journal: (JOURNAL)
- what: Specifically, the authors aimed to compare the prognostic utility of models using the continuous values of sFlt-1, PIGF, or sFlt-1/ PIGF ratio for predicting PE within 7 days of screening among those with suspected PE compared to the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.